Aeterna Zentaris
AEZS
#10803
Rank
โ‚ฌ15.65 M
Marketcap
5,11ย โ‚ฌ
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -1,90ย โ‚ฌ

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -1,83ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -4,18ย โ‚ฌ a decrease over its 2021 EPS that were of -1,63ย โ‚ฌ.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-1,90ย โ‚ฌ
2022-4,18ย โ‚ฌ157.14%
2021-1,63ย โ‚ฌ-41.48%
2020-2,78ย โ‚ฌ-64.46%
2019-7,82ย โ‚ฌ-240%
20185,59ย โ‚ฌ-122.32%
2017-25,03ย โ‚ฌ-53.53%
2016-53,87ย โ‚ฌ-86.71%
2015-405,47ย โ‚ฌ-35.21%
2014-625,87ย โ‚ฌ-216.67%
2013536,46ย โ‚ฌ-123.3%
2012-2.302ย โ‚ฌ-40.8%
2011-3.889ย โ‚ฌ-6.45%
2010-4.158ย โ‚ฌ-27.91%
2009-5.767ย โ‚ฌ-61.61%
2008-15.021ย โ‚ฌ83.61%
2007-8.181ย โ‚ฌ-195.31%
20068.583ย โ‚ฌ178.26%
20053.085ย โ‚ฌ-330%
2004-1.341ย โ‚ฌ-80.05%
2003-6.722ย โ‚ฌ17.78%
2002-5.708ย โ‚ฌ515.93%
2001-926,68ย โ‚ฌ-68.6%
2000-2.952ย โ‚ฌ133.02%
1999-1.267ย โ‚ฌ-3.63%
1998-1.314ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
5,95ย โ‚ฌ-425.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
1,70ย โ‚ฌ-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
4,06ย โ‚ฌ-321.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-0,32ย โ‚ฌ-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
3,15ย โ‚ฌ-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA